Anbio Biotechnology: xbrl:AccountsReceivableGrossCurrent
| Value | {"amount": 3655964, "currency": "USD"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/fd4640d1-0eef-4644-b93d-10d1567b2493
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001185185-26-001294Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/fd4640d1-0eef-4644-b93d-10d1567b2493
History
- no predecessors — first report